Target intelligence / Profile preview

Hantavirus envelope glycoprotein Gc (Gc)

Target
Gc
Molecular classification
Viral envelope protein, Class II fusion protein, Glycoprotein
01

Overview

Hantavirus envelope glycoprotein Gc is a critical structural component of the hantavirus virion, forming heterodimeric spikes with the Gn glycoprotein on the viral surface [1, 3]. It is classified as a class II viral fusion protein, responsible for mediating the fusion of the viral envelope with the host endosomal membrane in a low-pH environment during cell entry [5, 6]. Gc is a primary target for the host's neutralizing antibody response, making it a focal point for the development of vaccines and therapeutic monoclonal antibodies [11, 13]. Mutations in Gc can lead to viral escape from neutralization, and its complex conformational changes during fusion present both a challenge and an opportunity for drug design [5, 15]. The protein also plays a role in virus assembly and budding by interacting with the Gn protein and the viral nucleocapsid [1, 14].

Other names
G2Glycoprotein 2Hantavirus G2 proteinEnvelope glycoprotein G2Hantavirus Gc protein
02

Mechanism of action

Neutralization of viral entry and inhibition of pH-dependent membrane fusion

03

Biological functions

Viral entryMembrane fusionVirus assemblyReceptor bindingVirus budding
04

Disease associations

Hantavirus Pulmonary SyndromeHemorrhagic Fever with Renal SyndromeInfection
05

Safety considerations

Viral mutational escapeAntibody-dependent enhancementTherapeutic window in acute infection
06

Interacting drugs

MIB22

5 more in the full profile.

07

Biomarkers

Anti-Gc IgM antibodyAnti-Gc IgG antibodyViral RNA loadInterleukin-6

Beyond the preview

Go deeper on Hantavirus envelope glycoprotein Gc (Gc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hantavirus envelope glycoprotein Gc (Gc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call